Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol. Newman CB, Tobert JA. J Clin Endocrinol Metab 2023;108:784-790.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Newman CB, Tobert JA. Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol. J Clin Endocrinol Metab 2023;108:784-790.
PMID: 36469793